Your session is about to expire
← Back to Search
Technology-Enabled Skin Cancer Screening for Stem Cell Transplant Survivors
Study Summary
This trial is testing the impact of an invention for early detection of skin cancer in stem cell transplant survivors and their primary care providers.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had a stem cell transplant at City of Hope.I had a stem cell transplant between 2 and 5 years ago.I do not have an active blood cancer or severe illness that would prevent me from participating in the study.I can fluently read and write in English or Spanish.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals have been recruited to take part in this experiment?
"Indeed, the clinicaltrials.gov database suggests that this research is actively looking for volunteers. The trial was initially published on October 30th 2020 and its information has since been updated on May 23rd 2022. 720 participants are needed from a single site to fulfill their quota."
Is there currently a call for volunteers for this research project?
"Affirmative, clinicaltrials.gov attests to the ongoing recruitment for this trial which was inaugurated on October 30th 2020 and most recently refreshed on May 23rd 2022. To date, a total of 720 patients have need to be enrolled from 1 medical facility."
Share this study with friends
Copy Link
Messenger